Analyst Consensus ?
ConsensusBuy31 ratings
Bullish3096.8%
Neutral00.0%
Bearish13.2%
FN2 Earnings Intelligence
Guardant Health, Inc. analyst ratings
Guardant Health, Inc. (GH) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$148.96Current
$28Low
$154.85Average
$225High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Nov 6, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| BTIG | Buy | Buy | Maintain | Oct 27, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Oct 13, 2026 |
| Barclays | Overweight | Overweight | Maintain | Oct 7, 2026 |
| Guggenheim | Buy | Buy | Maintain | Oct 1, 2026 |
| UBS | Buy | Buy | Maintain | Sep 9, 2026 |
| Stephens & Co. | Overweight | Overweight | Maintain | Aug 4, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Aug 4, 2026 |
| Stifel | Buy | Buy | Maintain | Aug 3, 2026 |
| TD Cowen | Buy | Buy | Maintain | Jul 31, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jul 31, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Jul 31, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jul 31, 2026 |
| Canaccord Genuity | Buy | Buy | Maintain | Jul 14, 2026 |
| Citigroup | Buy | Buy | Maintain | Jul 8, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Jul 6, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jul 6, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Jul 2, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Jun 5, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Feb 20, 2026 |
| Leerink Partners | Outperform | Outperform | Maintain | Feb 20, 2026 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Sep 25, 2025 |
| Scotiabank | Sector Outperform | Sector Outperform | Maintain | Jul 31, 2025 |
| Raymond James | Outperform | Outperform | Maintain | Jul 31, 2025 |
| TD Securities | Buy | Buy | Maintain | May 1, 2025 |
| Craig-Hallum | Buy | Buy | Maintain | Aug 8, 2024 |
| Credit Suisse | Outperform | Outperform | Maintain | May 10, 2023 |
| OTR Global | Negative | Mixed | Downgrade | May 1, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Feb 24, 2023 |
| SVB Leerink | Outperform | Outperform | Maintain | Feb 24, 2022 |
| Bank of America | Buy | Neutral | Upgrade | Apr 10, 2019 |
| William Blair | Outperform | Outperform | Maintain | Oct 29, 2018 |
Named analyst price targets
Upside is calculated against the persisted current price $148.96. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| BTIG | Mark Massaro | $210 | $173.25 | +41.0% | Oct 27, 2026 |
| Morgan Stanley | Kallum Titchmarsh | $200 | $162.99 | +34.3% | Oct 12, 2026 |
| Barclays | Luke Sergott | $220 | $170.69 | +47.7% | Oct 7, 2026 |
| Guggenheim | Analyst unavailable | $200 | $177.24 | +34.3% | Oct 1, 2026 |
| Bernstein | Eve Burstein | $210 | $161.25 | +41.0% | Sep 10, 2026 |
| UBS | Analyst unavailable | $225 | $160.98 | +51.0% | Sep 9, 2026 |
| Redburn Partners | Analyst unavailable | $203 | $161.41 | +36.3% | Sep 8, 2026 |
| Morgan Stanley | Analyst unavailable | $185 | $160.36 | +24.2% | Aug 4, 2026 |
| Stephens | Analyst unavailable | $195 | $158.83 | +30.9% | Aug 4, 2026 |
| Piper Sandler | Analyst unavailable | $193 | $158.83 | +29.6% | Aug 4, 2026 |
| RBC Capital | Dan Leonard | $200 | $161.87 | +34.3% | Jul 31, 2026 |
| RBC Capital | Analyst unavailable | $210 | $161 | +41.0% | Jul 31, 2026 |
| Stifel Nicolaus | Daniel Arias | $180 | $152.35 | +20.8% | Jul 31, 2026 |
| Goldman Sachs | Analyst unavailable | $210 | $152.35 | +41.0% | Jul 31, 2026 |
| Mizuho Securities | Anthony Petrone | $200 | $152.35 | +34.3% | Jul 31, 2026 |
| BTIG | Mark Massaro | $195 | $152.35 | +30.9% | Jul 31, 2026 |
| Barclays | Analyst unavailable | $200 | $152.35 | +34.3% | Jul 31, 2026 |
| Guggenheim | Analyst unavailable | $190 | $162.96 | +27.6% | Jul 16, 2026 |
| Canaccord Genuity | Kyle Mikson | $205 | $158.4 | +37.6% | Jul 14, 2026 |
| Morgan Stanley | Analyst unavailable | $175 | $156.17 | +17.5% | Jul 9, 2026 |
| Evercore ISI | Vijay Kumar | $200 | $169.45 | +34.3% | Jul 6, 2026 |
| Bernstein | Eve Burstein | $200 | $170.77 | +34.3% | Jul 2, 2026 |
| BTIG | Analyst unavailable | $190 | $170.19 | +27.6% | Jul 1, 2026 |
| Guggenheim | Analyst unavailable | $160 | $149.22 | +7.4% | Jun 29, 2026 |
| UBS | Analyst unavailable | $150 | $130.83 | +0.7% | Jun 24, 2026 |
| RBC Capital | Dan Leonard | $185 | $130.9 | +24.2% | Jun 11, 2026 |
| Mizuho Securities | Analyst unavailable | $175 | $125.61 | +17.5% | Jun 8, 2026 |
| Goldman Sachs | Evie Koslosky | $165 | $133.06 | +10.8% | Jun 5, 2026 |
| Evercore ISI | Analyst unavailable | $160 | $129.14 | +7.4% | Jun 2, 2026 |
| BTIG | Analyst unavailable | $160 | $127.41 | +7.4% | May 27, 2026 |
| BTIG | Mark Massaro | $155 | $118.95 | +4.1% | May 26, 2026 |
| Piper Sandler | Analyst unavailable | $127 | $119.32 | -14.7% | May 21, 2026 |
| Piper Sandler | David Westenberg | $135 | $96.71 | -9.4% | May 12, 2026 |
| Barclays | Luke Sergott | $115 | $82.21 | -22.8% | Apr 14, 2026 |
| Piper Sandler | Analyst unavailable | $130 | $94.42 | -12.7% | Feb 24, 2026 |
| Raymond James | Analyst unavailable | $129 | $97.49 | -13.4% | Feb 23, 2026 |
| Evercore ISI | Analyst unavailable | $110 | $106.84 | -26.2% | Feb 20, 2026 |
| BTIG | Analyst unavailable | $145 | $106.38 | -2.7% | Feb 20, 2026 |
| Stifel Nicolaus | Analyst unavailable | $130 | $106.38 | -12.7% | Feb 20, 2026 |
| Canaccord Genuity | Analyst unavailable | $135 | $106.38 | -9.4% | Feb 20, 2026 |
| Barclays | Analyst unavailable | $130 | $106.38 | -12.7% | Feb 20, 2026 |
| Robert W. Baird | Catherine Schulte | $120 | $104.85 | -19.4% | Feb 17, 2026 |
| UBS | Analyst unavailable | $175 | $111 | +17.5% | Jan 30, 2026 |
| Guggenheim | Analyst unavailable | $135 | $115.69 | -9.4% | Jan 26, 2026 |
| Stifel Nicolaus | Analyst unavailable | $120 | $108.74 | -19.4% | Jan 9, 2026 |
| Mizuho Securities | Analyst unavailable | $135 | $108.74 | -9.4% | Jan 9, 2026 |
| Guggenheim | Subbu Nambi | $115 | $99 | -22.8% | Jan 5, 2026 |
| Evercore ISI | Vijay Kumar | $105 | $101.74 | -29.5% | Jan 5, 2026 |
| Canaccord Genuity | Analyst unavailable | $125 | $99.74 | -16.1% | Dec 22, 2025 |
| Mizuho Securities | Analyst unavailable | $120 | $100 | -19.4% | Dec 17, 2025 |
| Leerink Partners | Analyst unavailable | $155 | $104 | +4.1% | Dec 15, 2025 |
| Wells Fargo | Brandon Couillard | $120 | $102.04 | -19.4% | Dec 15, 2025 |
| Barclays | Analyst unavailable | $120 | $102.04 | -19.4% | Dec 15, 2025 |
| BTIG | Analyst unavailable | $140 | $101.34 | -6.0% | Dec 12, 2025 |
| Morgan Stanley | Tejas Savant | $130 | $105.22 | -12.7% | Dec 1, 2025 |
| UBS | Dan Leonard | $110 | $95.29 | -26.2% | Oct 30, 2025 |
| BTIG | Mark Massaro | $100 | $95.55 | -32.9% | Oct 30, 2025 |
| Mizuho Securities | Bradley Bowers | $100 | $72.27 | -32.9% | Oct 30, 2025 |
| Canaccord Genuity | Kyle Mikson | $100 | $72.27 | -32.9% | Oct 30, 2025 |
| Barclays | Analyst unavailable | $85 | $72.27 | -42.9% | Oct 30, 2025 |
| Piper Sandler | Analyst unavailable | $90 | $67.51 | -39.6% | Oct 22, 2025 |
| Barclays | Analyst unavailable | $70 | $62.65 | -53.0% | Oct 2, 2025 |
| Canaccord Genuity | Kyle Mikson | $75 | $60.18 | -49.7% | Sep 26, 2025 |
| Stifel Nicolaus | Analyst unavailable | $70 | $60.18 | -53.0% | Sep 25, 2025 |
| BTIG | Mark Massaro | $80 | $60.75 | -46.3% | Sep 25, 2025 |
| Stifel Nicolaus | Daniel Arias | $73 | $62.64 | -51.0% | Sep 25, 2025 |
| Wolfe Research | Doug Schenkel | $75 | $61.23 | -49.7% | Sep 25, 2025 |
| China Renaissance Securities (US) Inc. | Tempus AI | $70 | $49.9 | -53.0% | Jun 25, 2025 |
| Morgan Stanley | Analyst unavailable | $52 | $42.66 | -65.1% | Mar 5, 2025 |
| UBS | Dan Leonard | $40 | $27.68 | -73.1% | Aug 21, 2024 |
| Craig-Hallum | Bill Bonello | $37 | $31.36 | -75.2% | Aug 8, 2024 |
| Jefferies | Tycho Peterson | $40 | $33.96 | -73.1% | Aug 8, 2024 |
| BTIG | Mark Massaro | $50 | $35.28 | -66.4% | Jul 29, 2024 |
| Guggenheim | Subbu Nambi | $36 | $28.88 | -75.8% | Jun 28, 2024 |
| Canaccord Genuity | Kyle Mikson | $38 | $27.41 | -74.5% | Jun 4, 2024 |
| Jefferies | Tycho Peterson | $32 | $27.1 | -78.5% | Jun 3, 2024 |
| BTIG | Mark Massaro | $45 | $22.51 | -69.8% | May 23, 2024 |
| Canaccord Genuity | Kyle Mikson | $30 | $23.01 | -79.9% | May 22, 2024 |
| Craig-Hallum | Chase Knickerbocker | $28 | $17.94 | -81.2% | Apr 24, 2024 |
| Piper Sandler | David Westenberg | $40 | $27.59 | -73.1% | Sep 27, 2023 |
| Goldman Sachs | Analyst unavailable | $45 | $29.56 | -69.8% | Feb 6, 2023 |
| Morgan Stanley | Tejas Savant | $80 | $41.26 | -46.3% | Dec 16, 2022 |
| Canaccord Genuity | Kyle Mikson | $65 | $41.26 | -56.4% | Dec 16, 2022 |
| Stephens | Mason Carrico | $99 | $59.78 | -33.5% | Oct 5, 2022 |
| Goldman Sachs | Analyst unavailable | $80 | $54.25 | -46.3% | Aug 8, 2022 |
| J.P. Morgan | Julia Qin | $125 | $39.32 | -16.1% | May 9, 2022 |
| Goldman Sachs | Matthew Sykes | $160 | $117.9 | +7.4% | Jun 3, 2021 |
Track every rating change on GH the moment it posts. Free to start.
Start freeGet the GH recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.